// App-Quantinova.ai

BSH19‐PO‐175 : Glanzmann Thrombocythaemia with very mild bleeding phenotype

Researchers

Presenter

  • M. Tahhan

Principal Investigators

  • M. Makris

  • H. Watson

Medical Centers

  • Haematology, Aberdeen Royal Infirmary, Aberdeen

  • University of Sheffield, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Glanzmann thrombasthenia

  • Trauma

Biomarkers

  • Integrin subunit beta 3

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved